Keyword: London

The relocation will see Novartis set up in the White City Place development next to Imperial College London’s new campus.

The initiative is seeking to build on the progress of British cell and gene therapy university spinouts such as Autolus and Orchard Therapeutics.

Perhaps nothing is more divisive in Britain today than Brexit. But what does it mean for R&D?

New research out by the BMJ shows that half of tracked clinical trials across Europe “have not reported trials.”

FundamentalVR launched a virtual surgery platform that uses physical feedback to create a tactile, flight simulator-like experience for surgeons.

Sensyne Health plans to go public with a £60 million listing ($77 million) on the London Stock Exchange on Aug. 17.

An AI startup raised $1 million to develop “machine reading” programs to digest and distill published biomedical literature and research.

Endoscopic device maker Creo has been considering additional funding, following FDA clearance of its tool for removing colorectal polyps.

The European Medicines Agency has begun laying the foundation for its new Amsterdam headquarters, aiming to finish construction by November 2019.

The U.K. will endeavor to keep pace with the European Union’s impending changes in clinical trial procedures post-Brexit.